Samuel Butman
Interventional Cardiology · Cottonwood, AZNPI 1982616884
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (43.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Medtronic at 40.0% of the total. That places this record below the midpoint for interventional cardiology clinicians in AZ, where the typical reported total is $10,657.
Across 121 payments — averaging $89.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Merck$4K
- Astrazeneca UK Limited$1K
- Boston Scientific$215
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$188
- Amgen$152
- plus $695 from 19 others
Across 126 payments — averaging $5518.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$275K
- Novartis$171K
- AbbVie$107K
- Akcea Therapeutics, Inc.$41K
- Esperion Therapeutics, Inc.$27K
- Merck$25K
- plus $49K from 4 others
What the payments were for
- Speaking & faculty fees$3,18529%
- Travel & lodging$4,66943%
- Food & beverage$2,96827%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 40 | $4,333 |
| Merck | 7 | $3,772 |
| Astrazeneca UK Limited | 9 | $1,467 |
| Boston Scientific | 2 | $215 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $188 |
| Amgen | 10 | $152 |
| Johnson & Johnson | 8 | $125 |
| Novartis | 4 | $69 |
| Abbott | 2 | $68 |
| Amarin Pharma, Inc. | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Kowa Pharmaceuticals America, Inc. | 4 | $53 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Portola Pharmaceuticals, LLC | 1 | $26 |
| AstraZeneca | 2 | $25 |
| W. L. Gore & Associates, Inc. | 2 | $25 |
| EKOS Corporation | 1 | $25 |
| Grifols USA, LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Pfizer | 1 | $17 |
| Aegerion Pharmaceuticals, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Amryt Pharma Holdings Ltd | 1 | $14 |
| AbbVie | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,822 in reported general payments places this provider in the 50th percentile of 223 interventional cardiology providers in Arizona.
Other interventional cardiology in Cottonwood
- Paul SorajjaPhoenix$1.1M
- Hursh NaikAvondale$781K
- Thomas WaggonerTucson$617K
- Timothy ByrnePhoenix$614K
- Haidar YassinPhoenix$434K
- Kapildeo LotunTucson$365K
- Azimuddin KhawajaPeoria$199K
- Rahul SharmaPeoria$195K
- Taral PatelScottsdale$171K
- Akil LoliPhoenix$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.